Loading Events

Mereo BioPharma: R&D Update on Mereo’s Alvelestat Program for Alpha-1 Antitrypsin Deficiency Lung Disease

Untitled design-11
DATE: October 31, 2022
TIME: 8:00 AM EDT
LOCATION: Virtual

About The Event

Join us for an R&D Update with Mereo BioPharma Group plc (Mereo) featuring pulmonology experts Robert Stockley, MBBS (University Hospital Birmingham, UK) and Robert Sandhaus, MD, PhD (National Jewish Health, US). The call will feature an update on the alvelestat program for alpha-1 antitrypsin deficiency (AATD) and will include presentations from management.

A Q&A session will follow the presentations.

Event Speakers

Robert Stockley, MBBS

Robert Sandhaus, MD, PhD